FTC Intervenes in King Pharmaceuticals Acquisition of Rival Alpharma Inc.
Date
The Federal Trade Commission has issued a consent order to settle its charges that King Pharmaceuticals, Inc.’s proposed $1.6 billion acquisition of rival drug-maker Alpharma Inc. would be...